Trials / Completed
CompletedNCT06487065
Observational Retrospective Study To Characterize and Assess Clinical Outcomes of Patients Receiving Tezepelumab in the Framework Of Use in Special Situations Prior to Commercialisation in Spain
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 33 (actual)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to provide the first results on the use of tezepelumab under clinical practice conditions in severe asthma patients who participated in the "foreign medication supply" program in Spain.
Conditions
Timeline
- Start date
- 2024-06-17
- Primary completion
- 2024-10-25
- Completion
- 2024-10-25
- First posted
- 2024-07-05
- Last updated
- 2025-10-02
Locations
14 sites across 1 country: Spain
Source: ClinicalTrials.gov record NCT06487065. Inclusion in this directory is not an endorsement.